CLINICAL_TRIALS trial_result · 2011-10-26

Clinical Trial Update: Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia [Phase 2]

Summary

A phase 2 trial evaluating the combination of alemtuzumab and rituximab in high-risk, early-stage chronic lymphocytic leukemia has completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Mayo Clinic | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2011-10-26